Brief: Cyxone Receives Intention To Grant From EPO
Oct 9 (Reuters) - Cyxone AB CYXO.ST :
* RECEIVES INTENTION TO GRANT FROM THE EUROPEAN PATENT
OFFICE FOR
A UNITARY PATENT OF T20K
* PATENT COVERS PROTECTION OF DRUG CANDIDATE T20K THAT
CYXONE
LICENSES FROM MEDICAL UNIVERSITY OF VIENNA AND UNIVERSITY OF
FREIBURG
* WHEN APPROVED, PATENT WILL BE VALID UNTIL 2032
Source text for Eikon: ID:nWkr81zfNf
Further company coverage: CYXO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))